Forvis Mazars Guides €15m Investment in Tethis
Deal News | Feb 03, 2025 | Legal Community Italy
Forvis Mazars provided assistance to Fondazione Enea Tech e Biomedical in their €15 million investment in Tethis, a company specializing in innovative technologies for oncological diagnosis. The funding is intended to support the advancement and commercialization of Tethis' liquid biopsy solutions, which represent a cutting-edge advancement in early cancer detection and monitoring. The Forvis Mazars team, led by legal partner Massimiliano Vento and legal director Andrea Gambardella, along with Laura Serra and Luca Battilana, assisted Fondazione Enea in legal due diligence and contract negotiation. Legal senior managers Chiara Favaloro and Matteo Pollaroli oversaw employment due diligence. Ls Lexjus Sinacta handled financial and tax due diligence for Fondazione Enea, coordinated by Riccardo Acernese and Roberto Tombolesi. On the other hand, Alma Led, with the team led by partner Roberto Nigro, assisted Tethis and original investors Genextra and Indaco Venture Partners on behalf of Atlante Ventures, Indaco Ventures I and Indaco Ventures I Parallel Lombardia.
Sectors
- Biotechnology
- Private Equity
- Legal Services
Geography
- Italy – The transaction involves Italian firms and investment, with firms such as Forvis Mazars and Ls Lexjus Sinacta prominently participating in the deal.
Industry
- Biotechnology – The article is about the investment in Tethis, which is developing innovative oncological diagnostic technologies, fitting within the biotechnology sector.
- Private Equity – The investment by Fondazione Enea Tech e Biomedical involves the participation and support of private equity firms, highlighting the private equity sector's role.
- Legal Services – Legal services were essential in the transaction, involving firms like Forvis Mazars and Ls Lexjus Sinacta in due diligence and contract negotiations.
Financials
- €15 million – Investment by Fondazione Enea Tech e Biomedical in Tethis.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Tethis | Target Company | Company | A company focused on developing innovative technologies for oncological diagnosis. |
| Fondazione Enea Tech e Biomedical | Investor | Charity | The charitable foundation investing €15 million in Tethis to support the advancement of liquid biopsy technologies. |
| Forvis Mazars | Legal Advisor | Company | Provided legal support to Fondazione Enea for due diligence and negotiation processes. |
| Ls Lexjus Sinacta | Financial and Tax Advisor | Company | Handled financial and tax due diligence for Fondazione Enea. |
| Alma Led | Legal Advisor | Company | Assisted Tethis and its original investors with legal matters during the transaction. |
| Genextra | Investor | Company | An original investor in Tethis, participating in the transaction. |
| Indaco Venture Partners SGR | Investor | Company | Another original investor in Tethis, involved on behalf of specific venture funds. |
| Massimiliano Vento | Legal Partner | Person | Legal partner at Forvis Mazars leading the due diligence and contract negotiations. |
| Andrea Gambardella | Legal Director | Person | Legal director at Forvis Mazars, part of the team assisting Fondazione Enea. |